Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Home-based Primary Care for Homebound Seniors

Not Applicable

Terminated

Conditions: Home-bound Adults

Interventions: Other: Usual Care
Other: Home-based Primary Care

First Posted Date: 2016-11-16

Last Posted Date: 2020-10-19

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 230

Registration Number: NCT02965508

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Quarterback 2b - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer

Not Applicable

Active, not recruiting

Conditions: Locally Advanced HPV Positive Oropharynx Cancer

Interventions: Radiation: PTV56
Radiation: PTV50.4

First Posted Date: 2016-10-26

Last Posted Date: 2024-07-05

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 43

Registration Number: NCT02945631

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Study on the Effect of Ibrutinib on High Risk Smoldering Multiple Myeloma Patients

Phase 2

Terminated

Conditions: High Risk Smoldering Multiple Myeloma

Interventions: Drug: Ibrutinib

First Posted Date: 2016-10-24

Last Posted Date: 2020-12-16

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 9

Registration Number: NCT02943473

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

Phase 1

Terminated

Conditions: Breast Cancer

Interventions: Drug: Tamoxifen
Drug: Fulvestrant

First Posted Date: 2016-10-18

Last Posted Date: 2021-05-19

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 2

Registration Number: NCT02936206

Locations: 🇺🇸
Mount Sinai West, New York, New York, United States
🇺🇸
Mount Sinai St. Luke's, New York, New York, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Development of a Polyphenol-rich Dietary Preparation for Treating Veterans With Gulf War Illness

Phase 1

Completed

Conditions: Gulf War Illness

Interventions: Dietary Supplement: Concord grape juice
Dietary Supplement: Placebo Beverage

First Posted Date: 2016-09-26

Last Posted Date: 2020-06-29

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 36

Registration Number: NCT02915237

Locations: 🇺🇸
VA- New Jersey Health Care System, East Orange, New Jersey, United States

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Abiraterone acetate
Drug: Prednisone
Drug: Radium-223 dichloride
Drug: cabazitaxel
Drug: Carboplatin
Drug: Enzalutamide

First Posted Date: 2016-09-16

Last Posted Date: 2024-02-07

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 40

Registration Number: NCT02903160

Locations: 🇺🇸
Mount Sinai Beth Israel, New York, New York, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Neuromyelitis Optica (NMO) & Cetirizine

Phase 1

Completed

Conditions: Neuromyelitis Optica

Interventions: Drug: cetirizine

First Posted Date: 2016-08-12

Last Posted Date: 2023-06-07

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 16

Registration Number: NCT02865018

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Acupuncture for Post-Operative Pain Control for Patients Undergoing Gynecological Surgery

Not Applicable

Completed

Conditions: Post-operative Pain
Gynecological Surgery
Acupuncture

Interventions: Device: Acupuncture needles

First Posted Date: 2016-08-04

Last Posted Date: 2019-06-25

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 110

Registration Number: NCT02855567

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Autonomic Neuropathy, GI Motility, and Inflammation in HIV

Early Phase 1

Completed

Conditions: HIV Disease

Interventions: Drug: Pyridostigmine

First Posted Date: 2016-07-29

Last Posted Date: 2019-05-29

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 76

Registration Number: NCT02850276

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Compare Ultrasound Assisted Cold Therapy and Lidocaine Injection to Treat Morton's Neuroma

Phase 1

Completed

Conditions: Intermetatarsal Neuroma

Interventions: Drug: Saline
Drug: Lidocaine
Device: Cryoablation

First Posted Date: 2016-07-20

Last Posted Date: 2018-11-06

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 10

Registration Number: NCT02838758

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy